Cardiff Oncology Inc (NAS:CRDF)
$ 3.44 0.14 (4.24%) Market Cap: 153.85 Mil Enterprise Value: 88.66 Mil PE Ratio: 0 PB Ratio: 2.53 GF Score: 53/100

Cardiff Oncology, Inc. - Special Call Transcript

Sep 23, 2020 / 03:00PM GMT
Release Date Price: $11.35 (-3.07%)
Sara Parigian

Good day, and welcome to the Cardiff Oncology KOL call on KRAS in clinical practice for colorectal cancer. (Operator Instructions) As a reminder, this conference is being recorded, and a replay will be made available on the Cardiff Oncology website following the conclusion of the event.

I would now like to turn the call over to your host, Dr. Mark Erlander, Chief Executive Officer at Cardiff Oncology.

Please go ahead, sir.

Mark Erlander
Cardiff Oncology, Inc. - Chief Scientific Officer, CEO & Director

Thank you, operator, and good morning to all of you that have joined us today for today's key opinion leader event. Before I begin, I'd like to thank LifeSci Advisors for putting this event together as well as our key opinion leaders, Dr. Afsaneh Barzi and Dr. Heinz-Josef Lenz, for their time.

Today's event will focus on KRAS in colorectal cancer, beginning with a discussion by Dr. Barzi on the history of KRAS in clinical practice, the challenges of drug development and effectively targeting KRAS mutations and the current

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot